3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 1/2
1
Status
Recruiting
3
Terminated
1
Not yet recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
CNS
3
Conditions
Neoplasms
3
Brain Neoplasms
3
Radiation Pneumonitis
1
Radiation Injuries
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Optic Neuritis
1
Neoplasms, Fibrous Tissue
1
Neoplasms, Connective and Soft Tissue
1
Neoplasms, Connective Tissue
1
Neoplasms by Histologic Type
1
Neoplasm Metastasis
1
Myelitis, Transverse
1
Myelitis
1
Myasthenia Gravis
1
Musculoskeletal Diseases
1
Lung Neoplasms
1
Lung Diseases, Interstitial
1
Joint Diseases
1
Glioma
1
Fibroma
1
Dupuytren Contracture
1
Contracture
1
Connective Tissue Diseases
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Magnetic Resonance Spectroscopy
23
Radiosurgery
21
Temozolomide
14
Bevacizumab
11
pembrolizumab
10
Specimen Handling
9
Nivolumab
8
Radiotherapy
7
Ipilimumab
7
Magnetic Resonance Imaging
6
Cyclophosphamide
5
Capecitabine
5
Blood Specimen Collection
5
encorafenib
4
Radiation
4
Neuropsychological Tests
4
Mental Status and Dementia Tests
4
Memantine
4
Carboplatin
4
fludarabine
3
fluciclovine F-18
3
binimetinib
3
abemaciclib
3
Watchful Waiting
3
Proton Therapy
3
Etoposide
3
Dexamethasone
3
Adrenal Cortex Hormones
3
trastuzumab deruxtecan
2
sacituzumab govitecan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Recruiting
×
Brain Neoplasms
×
Adrenal Cortex Hormones
×
Clear all
NCT05789589
2026-03-04
ADORATION
Baptist Health South Florida
Phase 1/2
Recruiting
46 enrolled
NCT06888817
2026-02-25
BRAINS
The Netherlands Cancer Institute
Phase 3
Recruiting
408 enrolled
NCT06471465
2025-08-17
BRADI
Institut Cancerologie de l'Ouest
Phase 3
Recruiting
84 enrolled